Price To Earnings Ratio 17.83 | Sector PE 68.04 |
PB Ratio 4.23 | Sector PB 8.76 |
EPS 77.56 | Dividend Yield 1.00 |
Today's Volume 2.032 M | 5 Day Avg. Volume 1.064 M |
PEG Ratio 0.18 | Market Cap. ₹ 25,200.00 Cr. |
Time | NATCOPHARM | VS | Industry |
---|---|---|---|
1 Day | -1.26% | -1.92% | |
1 Week | -5.55% | -6.45% | |
1 Month | -1.3% | -7.86% | |
6 Months | 33.12% | 14.37% | |
1 Year | 96.43% | 49% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 1386.51 | Bearish |
20 | 1356.89 | Bullish |
30 | 1369.1 | Bullish |
50 | 1408.65 | Bearish |
100 | 1403.74 | Bearish |
200 | 1217.38 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 1211.60 | 849.10 | 46.50 | 298.80 | |||||
Investing Activities | -1032.70 | -477.10 | -5.30 | -103.30 | |||||
Financing Activities | -246.90 | -363.00 | 34.80 | -185.70 | |||||
Net Cash Flow | -68.00 | 9.00 | 76.00 | 9.80 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
NATCO Pharma | -1.26 | -5.55 | -1.3 | 33.12 | 96.43 |
Aarti Drugs | -2.2 | -5.85 | -7.94 | 4.92 | 3.39 |
Abbott India | -3.73 | -4.75 | -4.92 | 1.63 | 15.94 |
Advanced Enzyme Tech | -4.47 | -25.31 | -21.65 | -5.67 | 13.94 |
Ajanta Pharmaceuticals | -0.45 | -9.66 | -14.65 | 6.47 | 44.82 |
Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.